INTRODUCTION
The effects of cigarette smoking on pregnancy and fetal outcome, and recently on fertility, have been frequently investigated and reported. A reduction in fertility was shown by Jick et al. (1) and later confirmed by Baird and Wilcox (2), Stillmann et al., (3) and Laurent et al. (4) . MacMahon et al. (5) described lower estrogens in smokers compared with nonsmokers. Furthermore, smoking leads to earlier menopause (1), increased risk of ectopic pregnancy (6) , and impairment of semen parameters (3) . Several studies have hence attempted to establish whether smoking habits could influence in vitro fertilization (IVF) and embryo transfer (ET).
With the inclusion of our own data, it was the aim of this meta-analysis to assess the influence of the status of smokers on the pregnancy rate after IVF-ET.
METHODS
Our data were derived from the institute's IVF data bank, where we started to collect information about the patients' smoking habits in January 1996 to evaluate prospectively their influence on IVF success. Information about 799 patients (607 nonsmokers and 192 smokers) was obtained. After analyzing the ExcelSmoker data bank, it was established that this data bank was arranged on the basis of IVF cycles. From a biometrical point of view, only the results of the first IVF cycle are really well comparable, as the number of necessary IVF cycles always correlates with the number of pregnancies (when a patient wants to become pregnant, sometimes several IVF attempts are necessary; then, from a statistical point of view, the smoker status and the IVF result are always confounded). Therefore the smoker data bank was evaluated on the basis of first cycles, which contained the outcomes of 541 patients in their first IVF cycle (399 nonsmokers and 142 smokers) and was used in the meta-analysis.
Additional data were obtained from the following publications, which were retrieved under the search formulation "Smoking" and "Vitro and Publications offering pure cycle information without results with regard to "clinical pregnancy rates per patient" (14-16) were omitted. All the remaining references (A-G) were recalculated to first cycles according to possibility and the experiences from our own data bank.
Statistics
The strategy of analysis was explorative. All stated error probabilities were two-sided and referred to the individual test.
The statistic software is a proprietary development and was written in IBM APL2. This software was tested according to the rules of the European Organization for Quality, Section for Quality in the Pharmaceutical Industry, "Principles of Computer Use in a Regulated Pharmaceutical Industry" (1989) .
RESULTS
The total analysis shows, with a P value less than 0.01, significantly higher pregnancy rates (21%) in nonsmokers compared to smokers (14%) ( Table I and Fig. 1) . A statistically significant influence of the smoker status on the IVF-ET pregnancy rate is found in publications C and E (P < 0.05). Our material showed, in view of of the absolute success rate, the highest pregnancy rates of all: 31% at the first cycle. This was with a P value less than 0.001, significantly higher than the pooled pregnancy rates of 16% for all other publications without taking the smoker status into consideration.
Basically the eight pregnancy rates of references A-H could be interpreted as stochastically independent tests. We always find a higher success rate with nona These data were used for meta-analysis. * Correction of data according to the same method as in H. smokers compared to smokers, except in reference B, regarding the pregnancy rates of B as identical. Comparing these data in the nonparametric sign test according to Dixon-Mood, the nonsmokers have a seven times higher pregnancy rate and, in no case, a worse rate; thus, we derive with this model a statistically significant difference of P being less than 0.05. The relative success ratios are indicated in Fig. 2 and are defined as the quotients of the probability of IVF- ET success of nonsmokers divided by that of smokers for each publication. This success quotient thus shows how many IVF-ET cycles a smoker compared to a nonsmoker has to undergo to become pregnant. For this value, we obtain-after log-transformation of the raw data and back transformation-a success ratio of 1.79, with an associated 95% confidence interval of from 1.24 to 2.59 (Fig. 2) . Because this interval does not cover the number 1, the result can be interpreted as meaning that smoking reduces the chance of becoming pregnant by a factor close to 2 and that this effect has to be regarded as statistically significant.
DISCUSSION
Among other parameters in IVF such as age, body weight, baseline follicle stimulating hormone (FSH) levels, thickness and ultrasonic appearance of the endometrium, and uterine and ovarian perfusion, smoking has to be considered as an interfering factor. It may influence ovarian stimulation and oocyte and embryo quality, as well as implantation.
Rhodanate (thiocyanate), a marker for smoke exposure, was measured in serum and follicular fluid of IVF patients, and high concentrations were found (7). Cotinine, a marker for nicotine exposure, was detected in the follicular fluid of smoking women (17, 18) . Cadmium, a heavy metal in cigarette tobacco, was also found in follicles of smokers (19) , but none of these reports demonstrated a direct negative effect on oocyte or embryo quality. On the other hand, it has been shown that smoking has an influence on hormone levels, e.g., estradiol-17B serum levels were significantly decreased in women who smoked, compared with the results obtained from nonsmokers and passive smokers (8) . It was stated that smoking adversely affects ovulation induction parameters and alters the follicular fluid hormonal milieu (20) . Smokers produced fewer oocytes (9), and we found significantly lower embryo scores (21) , and also altered hormone parameters, when further analyzing our smokers' data (Feichtinger et al., in preparation).
There is also evidence that smokers who became pregnant showed a markedly increased rate of miscarriage (9, 14) , but it was impossible to include this important question in our meta-analysis, due to the limited number of publications mentioning miscarriage rates.
However, our statistical meta-analysis now demonstrates from a total of 2314 first IVF cycles, that smokers would need approximately twice as many attempts to get pregnant compared to nonsmokers, i.e., a significant negative effect on IVF pregnancy rates. The basic data of this meta-analysis, of course, do not prevailingly fulfill the criteria of prospective randomized placebo-controlled study designs in parallel groups. Furthermore, the number of cases in the evaluated publications partly differ significantly; uniform IVF-ET therapies and selection cannot be assumed. In view of the methodical weakness mentioned above, a certain caution in the final medical interpretation seems advisable regarding the accuracy of the results obtained. Regarding the degree of representativeness of this meta-analysis, this weakness has to be interpreted as a reversed positivum of a relatively high degree of representativeness, which is also based on the high number of cases.
In conclusion, these findings suggest that infertile women should be advised to quit or reduce smoking, particularly before treatment with IVF-ET. We agree with Rowlands et al. (16) that it has yet to be investigated how quickly the benefit of stopping may be gained.
